In the face of these multifaceted threats, the need for innovative healthcare solutions becomes increasingly urgent. It underscores the vital role of the biopharmaceutical industry in not only addressing immediate health crises but also contributing to the broader resilience and well-being of humanity in times of adversity.
Pfizer and BioNTech reported preliminary clinical data supporting use of their Covid-19 vaccine as a booster in children ages 5 to 11. In other Covid news, a vaccine developer won marketing authorization in Europe while another one faces a regulatory setback.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Pfizer and BioNTech say they have data supporting two-week storage of their vaccine at temperatures found in medical-grade freezers. They say FDA approval of an additional temperature option would give vaccination sites more flexibility.
The amended pact follows a collaboration begun last year when GlaxoSmithKline paid Vir Biotechnology $250 million to team up on potential treatments for Covid-19. The expansion includes an influenza treatment based on Vir's antibody technology.
Verily and Janssen say studying Covid-19 immune responses could yield data that helps clinicians treat the disease. They add that the research could also apply to other illnesses caused by respiratory pathogens.
Johnson & Johnson’s Covid-19 vaccine offers storage and distribution advantages compared to mRNA vaccines, and is the only single-shot vaccine to reach late-stage testing. The next stop is a Feb. 26 FDA advisory panel meeting.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Virtually connecting with patients can save providers time and money if they are able to use a platform that can encompass all of the tools needed to run their entire practice from the inside of their homes.
Dr. Lee Schwamm, vice president of virtual care/digital health at Mass General Brigham said this at the virtual event World Medical Innovation Forum hosted by Partners HealthCare on Monday.
A primary care Marshall Plan will involve all health insurers, plus the business leaders and state and local government officials who sign their contracts, to move to prospective payment (versus after-the-fact billing). By looking at what they paid for their beneficiaries’ primary care needs last year and awarding those physicians the same amount, insurers and plan sponsors will quite literally be investing in the nation’s future health and wellness.
If history is any indicator, expect the federal authorities to “aggressively pursue” medical professionals and others who hoard or unnecessarily prescribe chloroquine and hydroxychloroquine during the Covid-19 pandemic.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.